敦煌種業(600354.SH):擬變更經營範圍
格隆匯9月16日丨敦煌種業(600354.SH)公佈,公司於2022年9月16日以通訊方式召開八屆董事會第十五次臨時會議,審議通過了《關於變更公司經營範圍並修改<公司章程>的議案》。為了加快推進“甘肅省敦煌種業集團股份有限公司數字農業科創公司”(分公司)的啟動運行,公司擬對經營範圍新增與數字農業建設和運營服務相關內容,並修改《公司章程》中的相應條款。
公司擬對公司經營範圍進行變更,新增“農業專業及輔助性活動;智能農業管理;與農業生產經營有關的技術、信息、設施建設運營等服務;網絡技術服務;人工智能基礎資源與技術平台;衞星遙感應用系統集成;物聯網應用服務;軟件開發;互聯網數據服務;項目策劃與公關服務”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.